Preventive effect of MitoQ supplementation and endurance training on glioblastoma and its consequences: TLR4/CREB/ NF-κβ /IL-1β pathway and behaviors

IF 4.7 2区 医学 Q2 IMMUNOLOGY
Soheil Aminizadeh , Amir Hossein Moslemizadeh , Sara Sheibani , Zahra Sedighi-Khovidak , Zahrasadat Roholamini , Saeideh Jafarinejad-Farsangi , Reza Kheirandish , Vahid Sheibani , Hamideh Bashiri
{"title":"Preventive effect of MitoQ supplementation and endurance training on glioblastoma and its consequences: TLR4/CREB/ NF-κβ /IL-1β pathway and behaviors","authors":"Soheil Aminizadeh ,&nbsp;Amir Hossein Moslemizadeh ,&nbsp;Sara Sheibani ,&nbsp;Zahra Sedighi-Khovidak ,&nbsp;Zahrasadat Roholamini ,&nbsp;Saeideh Jafarinejad-Farsangi ,&nbsp;Reza Kheirandish ,&nbsp;Vahid Sheibani ,&nbsp;Hamideh Bashiri","doi":"10.1016/j.intimp.2024.113756","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>The present study investigated the preventive effect of MitoQ supplementation and endurance training (ET) on the TLR4/CREB/ NF-κβ signaling pathway, antioxidant indices, and behaviors in C6-induced glioblastoma (GBM) in rats.</div></div><div><h3>Methods</h3><div>60 male Wistar rats were randomly divided into five groups (n = 12); Sham, Tumor, MitoQ, ET, and MitoQ + ET. Rats in the training groups performed endurance training (5 days per week), and MitoQ at the dose of 250 µM/L daily was administered in drinking water for 8 weeks. At the end of the protocol, all groups except the sham group received 1*10<sup>6</sup> tumor cells /10 µl culture medium. Two weeks after tumor induction, behavioral tests were performed, and then brain tissue was collected for the histopathology, measurement of antioxidant and inflammatory factors, TLR4, NF-κB proteins, and TLR4, NF-κβ, CREB, IL-1ß, TNF-a, IL-10, Bax, Bcl-2, and Caspase-3 gene expression.</div></div><div><h3>Results</h3><div>The increased level of TLR4 and NF-κβ protein expression in GBM rats decreased in the treatment groups. Gene expression of TLR4, NF-κβ, CREB, TNF-a, IL-10, and Bcl-2 increased in the tumor groups, and treatment groups decreased TLR4, NF-κB, Bcl-2, and CREB. In addition, social behaviors, balance, and memory were impaired in the tumor group, which combination group could improve these behaviors.</div></div><div><h3>Conclusion</h3><div>In sum, the preventive effects of MitoQ as a beneficial immune reactive agent and exercise training in rats with C6-induced glioblastoma may be mediated via modulating oxidative stress, inflammatory factors, and down-regulation of the expression of TLR4.</div></div>","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":"145 ","pages":"Article 113756"},"PeriodicalIF":4.7000,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International immunopharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1567576924022781","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

The present study investigated the preventive effect of MitoQ supplementation and endurance training (ET) on the TLR4/CREB/ NF-κβ signaling pathway, antioxidant indices, and behaviors in C6-induced glioblastoma (GBM) in rats.

Methods

60 male Wistar rats were randomly divided into five groups (n = 12); Sham, Tumor, MitoQ, ET, and MitoQ + ET. Rats in the training groups performed endurance training (5 days per week), and MitoQ at the dose of 250 µM/L daily was administered in drinking water for 8 weeks. At the end of the protocol, all groups except the sham group received 1*106 tumor cells /10 µl culture medium. Two weeks after tumor induction, behavioral tests were performed, and then brain tissue was collected for the histopathology, measurement of antioxidant and inflammatory factors, TLR4, NF-κB proteins, and TLR4, NF-κβ, CREB, IL-1ß, TNF-a, IL-10, Bax, Bcl-2, and Caspase-3 gene expression.

Results

The increased level of TLR4 and NF-κβ protein expression in GBM rats decreased in the treatment groups. Gene expression of TLR4, NF-κβ, CREB, TNF-a, IL-10, and Bcl-2 increased in the tumor groups, and treatment groups decreased TLR4, NF-κB, Bcl-2, and CREB. In addition, social behaviors, balance, and memory were impaired in the tumor group, which combination group could improve these behaviors.

Conclusion

In sum, the preventive effects of MitoQ as a beneficial immune reactive agent and exercise training in rats with C6-induced glioblastoma may be mediated via modulating oxidative stress, inflammatory factors, and down-regulation of the expression of TLR4.
MitoQ补充和耐力训练对胶质母细胞瘤的预防作用及其后果:TLR4/CREB/ NF-κβ /IL-1β途径和行为
目的:研究补充MitoQ和耐力训练(ET)对大鼠c6诱导的胶质母细胞瘤(GBM) TLR4/CREB/ NF-κβ信号通路、抗氧化指标和行为的预防作用。方法:雄性Wistar大鼠60只,随机分为5组(n = 12);Sham, Tumor, MitoQ, ET和MitoQ + ET。训练组大鼠进行耐力训练(每周5天),每天250µM/L的MitoQ在饮用水中给予,持续8周。方案结束时,除假手术组外,其余各组均给予1*106个肿瘤细胞/10µl培养基。诱导肿瘤2周后行行为学检查,取脑组织进行组织病理学检查,检测抗氧化和炎症因子、TLR4、NF-κB蛋白、TLR4、NF-κβ、CREB、IL-1ß、TNF-a、IL-10、Bax、Bcl-2和Caspase-3基因表达。结果:各给药组GBM大鼠TLR4和NF-κβ蛋白的表达水平升高,但均降低。肿瘤组TLR4、NF-κβ、CREB、TNF-a、IL-10、Bcl-2基因表达升高,治疗组TLR4、NF-κB、Bcl-2、CREB基因表达降低。此外,肿瘤组的社会行为、平衡能力和记忆力均受到损害,联合治疗组可以改善这些行为。结论:综上所述,MitoQ作为有益的免疫反应剂和运动训练对c6诱导的胶质母细胞瘤大鼠的预防作用可能通过调节氧化应激、炎症因子和下调TLR4的表达来介导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.40
自引率
3.60%
发文量
935
审稿时长
53 days
期刊介绍: International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome. The subject material appropriate for submission includes: • Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders. • Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state. • Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses. • Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action. • Agents that activate genes or modify transcription and translation within the immune response. • Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active. • Production, function and regulation of cytokines and their receptors. • Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信